Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
Top Cited Papers
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 65 (6), 2309-2320
- https://doi.org/10.1111/j.1523-1755.2004.00653.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL StudyKidney International, 2003
- Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2002
- Diabetic nephropathy: Prevention and treatmentKidney International, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesThe New England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001
- Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathyKidney International, 1996
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyThe New England Journal of Medicine, 1996
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?Kidney International, 1990
- Selective effect of low protein diets in chronic renal diseases.BMJ, 1984